Skip to content

Drug interactions

Deferasirox + Tamoxifen

Severity: Minor

Deferasirox and Tamoxifen: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Deferasirox can induce CYP3A4 in some patients, which may reduce tamoxifen exposure. The clinical significance is uncertain because tamoxifen activation relies largely on CYP2D6 as well as CYP3A4.

What this interaction means in plain words

Deferasirox and Tamoxifen have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Deferasirox belongs to Miscellaneous; Tamoxifen belongs to Endocrine.

Evidence level: Low

Why it happens

Deferasirox may modestly alter CYP3A4 activity, changing tamoxifen metabolism; the direction and extent are not firmly established.

What to do

No empirical dose change; monitor clinical response to endocrine therapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deferasirox and Tamoxifen, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Deferasirox with Tamoxifen?

MediHelp rates the interaction as minor. Deferasirox and Tamoxifen have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Deferasirox can induce CYP3A4 in some patients, which may reduce tamoxifen exposure. The clinical significance is uncertain because tamoxifen activation relies largely on CYP2D6 as well as CYP3A4.

How serious is the interaction between Deferasirox and Tamoxifen?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose change; monitor clinical response to endocrine therapy.

What other medicines interact with Tamoxifen?

MediHelp also lists interactions of Tamoxifen with, for example, Amiodarone, Anastrozole, Bupropion. The full list is on the Tamoxifen page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in